Beijing Tiantan Biological Products Co., Ltd. (600161.SS) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Beijing Tiantan Biological Products Co., Ltd.
—
Beijing Tiantan Biological Products Co., Ltd. is led by CEO Hui Chuan Yang, employs 5,205 people, headquartered in Beijing, CN, publicly traded since 1998.
Beijing Tiantan Biological Products Co., Ltd. (600161.SS) stock trades at $12.14 with a market capitalization of $24.42B. The stock is valued at a price-to-earnings (P/E) ratio of 32.50, price-to-book of 2.05, price-to-sales of 4.32. Over the past 52 weeks the stock has ranged between $11.12 and $19.19, and currently trades 36.7% below its 52-week high. It pays a dividend yielding 1.18%.
On profitability, Beijing Tiantan Biological Products Co., Ltd. generates a return on equity (ROE) of 6.80%, an operating margin of 18.72%, a net profit margin of 13.39%.
The balance sheet shows a debt-to-equity ratio of 0.01 (debt below half of shareholders' equity), a current ratio of 6.98.
600161.SS has an average daily trading volume of 14,262,104 shares, a beta of 0.18 (historically less volatile than the overall market), 1.98B shares outstanding.
Official website: www.tiantanbio.com
Beijing Tiantan Biological Products Co., Ltd. (600161.SS) — frequently asked questions
What is Beijing Tiantan Biological Products Co., Ltd. (600161.SS) stock price today?
Beijing Tiantan Biological Products Co., Ltd. (600161.SS) is currently trading at $12.14, down 3.11% today.
What is 600161.SS P/E ratio?
Beijing Tiantan Biological Products Co., Ltd.'s P/E ratio is 32.50. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 600161.SS return on equity (ROE)?
Beijing Tiantan Biological Products Co., Ltd.'s return on equity (ROE) is 6.80%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Beijing Tiantan Biological Products Co., Ltd.'s market cap?
Beijing Tiantan Biological Products Co., Ltd. has a market capitalization of $24.42B.
Does 600161.SS pay a dividend?
Yes. Beijing Tiantan Biological Products Co., Ltd. currently yields 1.18%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 600161.SS carry?
Beijing Tiantan Biological Products Co., Ltd. has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 600161.SS's profit margin?
Beijing Tiantan Biological Products Co., Ltd. reports a net profit margin of 13.39% — the share of revenue left after every cost, including tax and interest.
What sector is 600161.SS in?
Beijing Tiantan Biological Products Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 600161.SS listed on?
Beijing Tiantan Biological Products Co., Ltd. trades on SHH under the ticker 600161.SS.
What is 600161.SS's 52-week range?
Over the last year Beijing Tiantan Biological Products Co., Ltd. has traded between $11.12 and $19.19.
Related — Stocks
Popular Stocks
Screens 600161.SS currently matches
On the figures above, Beijing Tiantan Biological Products Co., Ltd. passes the filters for 11 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, Large Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.